Organization
Novartis AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Novartis AG
... ever less tolerant of corporate corruption. Another big firm under pressure is Novartis, a Swiss drugmaker. Since 2016 it has been probed over whether it ...
... Holzkirchen - Sandoz, a Novartis division and the global leader in biosimilars, today announced that the European ...
... with fludarabine and alemtuzumab. On January 22, 2018, it was announced that Novartis intends to transition Arzerra for the treatment of CLL indications from commercial ...
... biosimilar in 12 months Holzkirchen, Germany, May 24, 2018 - Sandoz, a Novartis division and the global leader in biosimilars, today announced that the European ...
... - Alcon, the global leader in eye care and a division of Novartis, is launching its newest lubricant eye drop, Systane Complete, with the help ...
... EAST HANOVER - Novartis will present data from across its oncology portfolio at the upcoming 54th ...
... Basel - Novartis today announced that the US Food and Drug Administration (FDA) has approved ...
... Novartis' ill-fated contract with President Donald Trump's personal attorney has not only bedeviled ...
... administration that would protect the company from indirect effects of U.S. sanctions. Novartis, the Swiss pharmaceutical giant, announced that Felix R. Ehrat, a top lawyer ...
Subscribe now for full coverage on Novartis AG
Start My Free Trial